Unique anti-myeloma activity by thiazolidine-2,4-dione compounds with Pim inhibiting activity-Reference-Cited by-同舟云学术

Unique anti-myeloma activity by thiazolidine-2,4-dione compounds with Pim inhibiting activity

Published:2018-01 Issue:2 Volume:180 Page:246-258
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Fujii Shiro¹^ORCID,Nakamura Shingen¹^ORCID,Oda Asuka¹,Miki Hirokazu²,Tenshin Hirofumi³,Teramachi Jumpei⁴,Hiasa Masahiro⁵,Bat-Erdene Ariunzaya¹,Maeda Yusaku¹,Oura Masahiro¹,Takahashi Mamiko¹,Iwasa Masami¹,Endo Itsuro¹,Yoshida Sumiko¹,Aihara Ken-ichi¹,Kurahashi Kiyoe¹,Harada Takeshi¹,Kagawa Kumiko¹,Nakao Michiyasu⁶,Sano Shigeki⁶,Abe Masahiro¹

Affiliation:

1. Department of Haematology, Endocrinology and Metabolism; Tokushima University Graduate School; Tokushima Japan

2. Division of Transfusion Medicine and Cell Therapy; Tokushima University hospital; Tokushima Japan

3. Department of Orthodontics and Dentofacial Orthopaedics; Tokushima University Graduate School; Tokushima Japan

4. Department of Histology and Oral Histology; Tokushima University Graduate School; Tokushima Japan

5. Department of Biomaterials and Bioengineerings; Tokushima University Graduate School; Tokushima Japan

6. Department of Molecular Medicinal Chemistry; Tokushima University Graduate School of Biomedical Sciences; Tokushima Japan

Funder

Ministry of Health, Labour and Welfare of Japan

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15033/fullpdf

Reference48 articles.

1. Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma;Abe;Blood,2002

2. Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion;Abe;Blood,2004

3. BAFF and APRIL as osteoclast-derived survival factors for myeloma cells: a rationale for TACI-Fc treatment in patients with multiple myeloma;Abe;Leukemia,2006

4. Control of Pim2 kinase stability and expression in transformed human haematopoietic cells;Adam;Bioscience Reports,2015

5. Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance;Allen;Cancer Research,2000

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the ubiquitin pathway in lymphoid malignancies;Cancer Letters;2024-07

2. PIM2 Kinase Regulates TIGIT Expression and Function in NK Cells from Multiple Myeloma Patients;2024-02-16

3. Acute suppression of translation by hyperthermia enhances anti-myeloma activity of carfilzomib;International Journal of Hematology;2024-01-22

4. Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors;International Journal of Hematology;2024-01-21

5. Rhodanine-Based Chromophores: Fast Access to Capable Photoswitches and Application in Light-Induced Apoptosis;Journal of the American Chemical Society;2024-01-11